Literature DB >> 1947747

Immunoassay standardization.

R Ekins1.   

Abstract

Assays employed in the biological sciences fall into two categories, which may be respectively termed "comparative" (or "functionally-specific") and "analytical" (or "structurally-specific"). The former are intended to compare the relative effects of substances, or mixtures of substances--not necessarily of identical chemical structure--on a biological system (e.g. whole animal, tissue, cell, etc). Results are represented by units of effect (i.e. they are not units of "amount" of the substance(s) measured), and differ depending on the biological system used. Such assays cannot be "standardised" by the use of a calibrant. In contrast, analytical assays are intended to measure the number of molecules (or mass) of a single substance of unique chemical structure in a test sample, and cannot legitimately be employed to measure mixtures of substances of different structure. Results are represented by units of molecular number or mass, and should be identical for any test sample irrespective of the assay system used. Immunoassays generally fall into this category. Insofar as the antigenic substances present in standards or test samples are dissimilar and/or molecularly heterogeneous, an immunoassay is invalid, and the results it yields have no universal significance. Attempts to standardize "analytically-invalid" immunoassays inevitably fail. Many substances of biological interest (e.g. TSH)--initially defined in terms of their biological function--have subsequently been shown to be molecularly heterogenous. Problems thus arise in the standardization of immunoassays used for their measurement, reflecting the fact that the measurement of a mixture of substances of differing molecular structure (and function) is a meaningless concept. It is thus impossible to "measure TSH"; it is only possible to measure the effect TSH exerts in a particularly assay system. The only long-term solution to this problem is the development of assay systems measuring individual components of such heterogenous mixtures.

Mesh:

Substances:

Year:  1991        PMID: 1947747     DOI: 10.3109/00365519109104600

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest Suppl        ISSN: 0085-591X


  5 in total

1.  Heterogeneity in buffalo pituitary prolactin.

Authors:  S Khurana; K Muralidhar
Journal:  Mol Cell Biochem       Date:  1997-08       Impact factor: 3.396

Review 2.  Biomarkers, validation and pharmacokinetic-pharmacodynamic modelling.

Authors:  Wayne A Colburn; Jean W Lee
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

3.  Variability among TSH Measurements Can Be Reduced by Combining a Glycoengineered Calibrator to Epitope-Defined Immunoassays.

Authors:  Sandrine Donadio-Andréi; Karim Chikh; Christine Heuclin; Elisabetta Kuczewski; Anne Charrié; Anne-Sophie Gauchez; Catherine Ronin
Journal:  Eur Thyroid J       Date:  2016-12-22

4.  Development and analytic validation of an enzyme-linked immunosorbent assay for the measurement of canine pancreatic lipase immunoreactivity in serum.

Authors:  Jörg M Steiner; Sheila R Teague; David A Williams
Journal:  Can J Vet Res       Date:  2003-07       Impact factor: 1.310

Review 5.  Growth hormone assays: current methodologies and their limitations.

Authors:  Martin Bidlingmaier; Christian J Strasburger
Journal:  Pituitary       Date:  2007       Impact factor: 3.599

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.